识别老年人群药物相关伤害预测因素的潜在类别分析
本研究基于Adverse Drug reactions in an Ageing PopulaTion队列(N=798例≥65岁急性入院患者),应用潜在类别分析识别药物类别与临床预测因素的潜在分组。确定五类模型,其中高风险处方合并多重用药组和高风险处方单独组更易发生药物不良反应相关入院,前者功能受损也更显著。基于用药特征识别老年亚组可能有助于制定针对性干预以减少药物相关伤害。
要点
- 五类模型中高风险处方合并多重用药组与高风险处方单独组ADR相关入院风险升高。
- 高风险处方合并多重用药组功能受损评分显著高于低风险组。
- 基于用药特征的潜在类别分组可用于识别药物相关伤害高风险老年人。
核心结论
- 基于用药特征识别老年人群的不同亚组,可能有助于制定更有针对性的干预措施以减少潜在药物相关伤害。
研究设计与样本
- 研究使用Adverse Drug reactions in an Ageing PopulaTion队列,纳入798例年龄≥65岁急性入院患者。
- 以7类药物(抗血栓药、利尿剂、肾素-血管紧张素-醛固酮系统药、钙通道阻滞剂、β受体阻滞剂、精神兴奋药、非甾体抗炎药)及共病、衰弱、显著多重用药(10种以上不同药物类别)为潜在预测因素。
- 采用潜在类别分析确定最佳类别数,并用单因素和多因素logistic、线性及Poisson回归模型检验潜在组与药物相关伤害结局的关联。
主要发现
- 确定五类模型拟合最佳:高风险处方合并多重用药组(N=245)、低风险组(n=138)、仅高风险处方组(N=332)、抗高血压组(N=18)、精神兴奋药合并多重用药组(N=65)。
- 高风险处方合并多重用药组ADR相关入院风险升高(a.OR=2.59,95%CI=1.51-4.44)。
- 仅高风险处方组ADR相关入院风险升高(a.OR=2.85,95%CI=1.57-5.20)。
- 高风险处方合并多重用药组功能受损评分显著高于低风险组(β=1.21,95%CI=0.09-2.33)。
关键数值与推荐
- 显著多重用药定义为10种以上不同药物类别。
- 药物相关伤害结局包括ADR相关入院、健康相关生活质量、功能受损和急诊就诊。
临床怎么用
- 对老年急性入院患者可结合药物类别、共病、衰弱和多重用药特征进行潜在类别分组,识别高风险处方合并多重用药等高危亚组。
- 对识别出的高风险亚组应优先评估药物相关伤害风险,并考虑针对性用药优化干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to apply latent class analysis to identify underlying groupings of predictors, including drug classes and clinical predictors, co-occurring in older people at higher risk of medication-related harm. METHOD: The Adverse Drug reactions in an Ageing PopulaTion cohort was used (N = 798 patients aged ≥65 years admitted acutely to hospital). Seven drug classes; antithrombotic agents, diuretics, renin-angiotensin-aldosterone system, calcium channel blockers, beta-blocking agents, psychoanaleptics, non-steroidal anti-inflammatory drugs, and comorbidity, frailty and significant polypharmacy (10+ different drug classes) were included as potential predictors of medication-related harm. Medication-related harm outcomes included adverse drug reactions (ADR)-related hospital admissions, health-related quality of life, functional impairment and emergency department visits. Determination of the best number of latent classes was based on standard comparison of fit statistics. Univariate and multivariable logistic, linear and Poisson regression models were used to examine the associations between the latent groups and the medication-related harm outcomes. RESULTS: A five class model was determined to fit best; (i) high-risk prescribing and polypharmacy group (N = 245); (ii) low-risk group (n = 138); (iii) high-risk prescribing only group (N = 332); (iv) antihypertensive group (N = 18); and (v) psychoanaleptics and polypharmacy group (N = 65). Patients in both the high-risk prescribing and polypharmacy group (a.OR = 2.59, 95%CI = 1.51-4.44) and the high-risk prescribing only group (a.OR = 2.85, 95%CI = 1.57-5.20) were more likely to have an ADR-related hospital admission, with the high-risk prescribing and polypharmacy group also having statistically significant higher functional impairment (β = 1.21, 95% CI = 0.09, 2.33) compared to those in the low-risk group. CONCLUSION: Identifying distinct subgroups of older people based on their medications may lead to more targeted and tailored interventions to reduce potential medication-related harm.
引用
- Brannigan R, Frydenlund J, Williams DJ, et al. Identifying predictors of medication-related harm in older populations: a latent class analysis approach. Age Ageing. 2025. PMID: 40838775. doi:10.1093/ageing/afaf227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。